NATURE . COM {}

Matching Content Categories {📚}

• Education
• Science
• Insurance

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.

Keywords {🔍}

retinal, ischemic, kus, injury, control, cell, layer, article, group, cells, rats, thickness, retina, pubmed, google, scholar, vcp, insult, fig, doi, rgcs, ganglion, ischemia, days, death, effects, outer, neuroprotective, images, nuclear, cas, rat, kustreated, research, stress, model, nature, significantly, bwave, protein, number, diseases, treatment, test, treated, groups, sections, rgc, chop, error,

Topics {✒️}

nature portfolio privacy policy nature genetics 36 nature advertising social media monosodium iodoacetate-induced osteoarthritis pressure-induced ischaemia-reperfusion insult index 0/ reprints author information authors cell death-inducing insults pct/jp2011/067320&pct/jp2011/073160 japan research foundation er stress-induced molecule author correspondence facial nerve research er stress-reducing activities integrated medical bio-imaging nampt-dependent nad+ salvage transgenic thy1-gfp rat proteasome-mediated protein degradation joint research project flat-mounted retinal imaging light-emitting diode stimulator ganglion cell complex fewer tunel-positive cells thy1-green fluorescent protein decreased b-wave amplitude investigator-initiated clinical trial fewer chop-positive rgcs ivt-kus121–treated group compared flat-mounted retinal images ischemia-reperfusion injured retina flat-mounted retinas treated ganglion cell layer profound anti-apoptotic effect retinal ischemia-reperfusion injury permissions 5 mg/kg body weight colorimetric-tdt enzyme assessed b-wave amplitudes vcp/p97 aaa-atpase neuronal cell death human subjects subjected anti-cleaved caspase-3 antibody induces cell death necrotic cell death gfp-positive rgc numbers japan national society

Schema {🗺️}

WebPage:
      mainEntity:
         headline:KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
         description:Ischemic neural damages cause several devastating diseases, including brain stroke and ischemic retinopathies, and endoplasmic reticulum (ER) stress has been proposed to be the underlying mechanism of the neuronal cell death of these conditions. We previously synthesized Kyoto University substances (KUSs) as modulators of valosin-containing protein (VCP); KUSs inhibit VCP ATPase activity and protect cells from different cell death-inducing insults. Here, we examined the efficacy of KUS121 in a rat model of retinal ischemic injury. Systemic administration of KUS121 to rats with ischemic retinal injury significantly suppressed inner retinal thinning and death of retinal ganglion and amacrine cells, with a significant functional maintenance of visual functions, as judged by electroretinography. Furthermore, intravitreal injection of KUS121, which is the clinically preferred route of drug administration for retinal diseases, appeared to show an equal or better neuroprotective efficacy in the ischemic retina compared with systemic administration. Indeed, induction of the ER stress marker C/EBP homologous protein (CHOP) after the ischemic insult was significantly suppressed by KUS121 administration. Our study suggests VCP modulation by KUS as a promising novel therapeutic strategy for ischemic neuronal diseases.
         datePublished:2017-03-20T00:00:00Z
         dateModified:2017-03-20T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/srep44873
         keywords:
            Drug discovery
            Neurological disorders
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig5_HTML.jpg
         isPartOf:
            name:Scientific Reports
            issn:
               2045-2322
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Masayuki Hata
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanako O. Ikeda
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chinami Kikkawa
               affiliation:
                     name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
                     address:
                        name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sachiko Iwai
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuki Muraoka
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tomoko Hasegawa
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Kakizuka
               affiliation:
                     name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
                     address:
                        name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nagahisa Yoshimura
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
      description:Ischemic neural damages cause several devastating diseases, including brain stroke and ischemic retinopathies, and endoplasmic reticulum (ER) stress has been proposed to be the underlying mechanism of the neuronal cell death of these conditions. We previously synthesized Kyoto University substances (KUSs) as modulators of valosin-containing protein (VCP); KUSs inhibit VCP ATPase activity and protect cells from different cell death-inducing insults. Here, we examined the efficacy of KUS121 in a rat model of retinal ischemic injury. Systemic administration of KUS121 to rats with ischemic retinal injury significantly suppressed inner retinal thinning and death of retinal ganglion and amacrine cells, with a significant functional maintenance of visual functions, as judged by electroretinography. Furthermore, intravitreal injection of KUS121, which is the clinically preferred route of drug administration for retinal diseases, appeared to show an equal or better neuroprotective efficacy in the ischemic retina compared with systemic administration. Indeed, induction of the ER stress marker C/EBP homologous protein (CHOP) after the ischemic insult was significantly suppressed by KUS121 administration. Our study suggests VCP modulation by KUS as a promising novel therapeutic strategy for ischemic neuronal diseases.
      datePublished:2017-03-20T00:00:00Z
      dateModified:2017-03-20T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/srep44873
      keywords:
         Drug discovery
         Neurological disorders
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig5_HTML.jpg
      isPartOf:
         name:Scientific Reports
         issn:
            2045-2322
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Masayuki Hata
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanako O. Ikeda
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chinami Kikkawa
            affiliation:
                  name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
                  address:
                     name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sachiko Iwai
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuki Muraoka
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tomoko Hasegawa
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Kakizuka
            affiliation:
                  name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
                  address:
                     name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nagahisa Yoshimura
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Scientific Reports
      issn:
         2045-2322
      volumeNumber:7
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
      address:
         name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
      address:
         name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Masayuki Hata
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Hanako O. Ikeda
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chinami Kikkawa
      affiliation:
            name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
            address:
               name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
               type:PostalAddress
            type:Organization
      name:Sachiko Iwai
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Yuki Muraoka
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Tomoko Hasegawa
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Akira Kakizuka
      affiliation:
            name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
            address:
               name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Nagahisa Yoshimura
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan

Social Networks {👍}(2)

• https://www.facebook.com/scientificreports
• https://twitter.com/SciReports

External Links {🔗}(120)

• Learn how profitable https://doi.org/10.1161%2FCIR.0b013e31823ac046 is on a monthly basis
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22179539
• How much does http://scholar.google.com/scholar_lookup?&title=Heart%20disease%20and%20stroke%20statistics%E2%80%932012%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association&journal=Circulation&doi=10.1161%2FCIR.0b013e31823ac046&volume=125&pages=e2-e220&publication_year=2012&author=Roger%2CVL generate monthly?
• How much money does https://doi.org/10.1016%2Fj.jemermed.2012.05.005 make?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22818644?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Tissue%20plasminogen%20activator%20and%20stroke%3A%20review%20of%20the%20literature%20for%20the%20clinician&journal=J%20Emerg%20Med&doi=10.1016%2Fj.jemermed.2012.05.005&volume=43&pages=1149-1154&publication_year=2012&author=DeMers%2CG&author=Meurer%2CWJ&author=Shih%2CR&author=Rosenbaum%2CS&author=Vilke%2CGM?
• What's https://doi.org/10.1016%2Fj.preteyeres.2003.12.001's gross income?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Retinal%20ischemia%3A%20mechanisms%20of%20damage%20and%20potential%20therapeutic%20strategies&journal=Prog%20Retin%20Eye%20Res&doi=10.1016%2Fj.preteyeres.2003.12.001&volume=23&pages=91-147&publication_year=2004&author=Osborne%2CNN
• How much profit does https://doi.org/10.1167%2Fiovs.06-0510 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17197555 pull in monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Retinal%20ischemia%20and%20reperfusion%20causes%20capillary%20degeneration%3A%20similarities%20to%20diabetes&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.06-0510&volume=48&pages=361-367&publication_year=2007&author=Zheng%2CL&author=Gong%2CB&author=Hatala%2CDA&author=Kern%2CTS bring in?
• How much cash flow does https://link.springer.com/doi/10.1007/BF00155046 have monthly?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=817878 is on a monthly basis
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Tributary%20vein%20obstruction%3A%20pathogenesis%20and%20treatment%20of%20sequelae&journal=Doc%20Ophthalmol&doi=10.1007%2FBF00155046&volume=40&pages=339-360&publication_year=1976&author=Archer%2CDB?
• What are the total earnings of https://doi.org/10.1038%2Fsj.cdd.4401365?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14752508
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Ischemia-induced%20neuronal%20cell%20death%20is%20mediated%20by%20the%20endoplasmic%20reticulum%20stress%20pathway%20involving%20CHOP&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4401365&volume=11&pages=403-415&publication_year=2004&author=Tajiri%2CS
• Get to know https://doi.org/10.1016%2Fj.neulet.2014.05.042's earnings
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24880098 net monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=Down-regulation%20of%20GRP78%20enhances%20apoptosis%20via%20CHOP%20pathway%20in%20retinal%20ischemia-reperfusion%20injury&journal=Neurosci%20Lett&doi=10.1016%2Fj.neulet.2014.05.042&volume=575&pages=68-73&publication_year=2014&author=Li%2CH&author=Zhu%2CX&author=Fang%2CF&author=Jiang%2CD&author=Tang%2CL generate?
• How much money does https://doi.org/10.1016%2Fj.brainres.2009.10.025 make?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19853589's financial summary
• Income figures for http://scholar.google.com/scholar_lookup?&title=Retinal%20ganglion%20cell%20death%20induced%20by%20endoplasmic%20reticulum%20stress%20in%20a%20chronic%20glaucoma%20model&journal=Brain%20Res&doi=10.1016%2Fj.brainres.2009.10.025&volume=1308&pages=158-166&publication_year=2010&author=Doh%2CSH&author=Kim%2CJH&author=Lee%2CKM&author=Park%2CHY&author=Park%2CCK
• What's the financial intake of https://doi.org/10.2147%2FOPTH.S3009?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19668425 pull in?
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699777 generate?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Increased%20expression%20of%20IRE1alpha%20and%20stress-related%20signal%20transduction%20proteins%20in%20ischemia-reperfusion%20injured%20retina&journal=Clin%20Ophthalmol&doi=10.2147%2FOPTH.S3009&volume=2&pages=743-752&publication_year=2008&author=Hata%2CN&author=Oshitari%2CT&author=Yokoyama%2CA&author=Mitamura%2CY&author=Yamamoto%2CS?
• What's the monthly income of https://doi.org/10.1038%2Fsj.cdd.4400955?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11859409 generate?
• How much money does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20ter94%2C%20Drosophila%20VCP%2C%20as%20a%20modulator%20of%20polyglutamine-induced%20neurodegeneration&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4400955&volume=9&pages=264-273&publication_year=2002&author=Higashiyama%2CH make?
• How much income does https://doi.org/10.1038%2Fng1332 have?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15034582's gross income?
• http://scholar.google.com/scholar_lookup?&title=Inclusion%20body%20myopathy%20associated%20with%20Paget%20disease%20of%20bone%20and%20frontotemporal%20dementia%20is%20caused%20by%20mutant%20valosin-containing%20protein&journal=Nature%20genetics&doi=10.1038%2Fng1332&volume=36&pages=377-381&publication_year=2004&author=Watts%2CGD's total income per month
• What are the earnings of https://doi.org/10.1016%2Fj.neuron.2010.11.036?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21145000 net monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032425 generate?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Exome%20sequencing%20reveals%20VCP%20mutations%20as%20a%20cause%20of%20familial%20ALS&journal=Neuron&doi=10.1016%2Fj.neuron.2010.11.036&volume=68&pages=857-864&publication_year=2010&author=Johnson%2CJO generate?
• How much income is https://doi.org/10.1016%2Fj.tibs.2011.06.001 earning monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21741246's financial summary
• How much income does http://scholar.google.com/scholar_lookup?&title=Cdc48%3A%20a%20power%20machine%20in%20protein%20degradation&journal=Trends%20Biochem%20Sci&doi=10.1016%2Fj.tibs.2011.06.001&volume=36&pages=515-523&publication_year=2011&author=Stolz%2CA&author=Hilt%2CW&author=Buchberger%2CA&author=Wolf%2CDH have?
• What's the monthly income of https://doi.org/10.1038%2Fncb2407?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22298039 have?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Emerging%20functions%20of%20the%20VCP%2Fp97%20AAA-ATPase%20in%20the%20ubiquitin%20system&journal=Nat%20Cell%20Biol&doi=10.1038%2Fncb2407&volume=14&pages=117-123&publication_year=2012&author=Meyer%2CH&author=Bug%2CM&author=Bremer%2CS
• Learn how profitable https://doi.org/10.1016%2Fj.bbamcr.2011.09.002 is on a monthly basis
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21945179 make?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=The%20Cdc48%20machine%20in%20endoplasmic%20reticulum%20associated%20protein%20degradation&journal=Biochim%20Biophys%20Acta&doi=10.1016%2Fj.bbamcr.2011.09.002&volume=1823&pages=117-124&publication_year=2012&author=Wolf%2CDH&author=Stolz%2CA?
• How much income does https://doi.org/10.1038%2Fsrep05970 have?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25096051 pull in monthly?
• What is the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122966?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Novel%20VCP%20modulators%20mitigate%20major%20pathologies%20of%20rd10%2C%20a%20mouse%20model%20of%20retinitis%20pigmentosa&journal=Sci%20Rep&doi=10.1038%2Fsrep05970&volume=4&publication_year=2014&author=Ikeda%2CHO generate?
• Learn about the earnings of https://doi.org/10.1038%2Fsrep31184
• How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2016NatSR...631184H generate monthly?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27503804
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977562 income
• Income figures for http://scholar.google.com/scholar_lookup?&title=Neuroprotective%20efficacies%20by%20KUS121%2C%20a%20VCP%20modulator%2C%20on%20animal%20models%20of%20retinal%20degeneration&journal=Sci%20Rep&doi=10.1038%2Fsrep31184&volume=6&publication_year=2016&author=Hasegawa%2CT
• https://doi.org/10.1001%2Farchfacial.2010.71's financial summary
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20855773?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=A%20new%20model%20for%20facial%20nerve%20research%3A%20the%20novel%20transgenic%20Thy1-GFP%20rat&journal=Arch%20Facial%20Plast%20Surg&doi=10.1001%2Farchfacial.2010.71&volume=12&pages=315-320&publication_year=2010&author=Magill%2CCK&author=Moore%2CAM&author=Borschel%2CGH&author=Mackinnon%2CSE?
• What's the income generated by https://doi.org/10.1016%2FS0014-4835%2805%2980173-3 each month?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1483506
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Cell%20death%20in%20the%20rat%20retina%20after%20a%20pressure-induced%20ischaemia-reperfusion%20insult%3A%20an%20electron%20microscopic%20study.%20I.%20Ganglion%20cell%20layer%20and%20inner%20nuclear%20layer&journal=Exp%20Eye%20Res&doi=10.1016%2FS0014-4835%2805%2980173-3&volume=55&pages=605-613&publication_year=1992&author=Buchi%2CER?
• How much does https://doi.org/10.1167%2Fiovs.07-1211 generate monthly?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18689704?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Imaging%20mouse%20retinal%20ganglion%20cells%20and%20their%20loss%20in%20vivo%20by%20a%20fundus%20camera%20in%20the%20normal%20and%20ischemia-reperfusion%20model&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.07-1211&volume=49&pages=5546-5552&publication_year=2008&author=Murata%2CH generate?
• How much does https://doi.org/10.1167%2Fiovs.13-13372 gross monthly?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Loss%20of%20inner%20retinal%20neurons%20after%20retinal%20ischemia%20in%20rats&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.13-13372&volume=55&pages=2777-2787&publication_year=2014&author=Schmid%2CH&author=Renner%2CM&author=Dick%2CHB&author=Joachim%2CSC
• How much does https://doi.org/10.1016%2Fj.preteyeres.2007.09.003 generate monthly?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18042420
• What's the income of http://scholar.google.com/scholar_lookup?&title=Rodent%20electroretinography%3A%20methods%20for%20extraction%20and%20interpretation%20of%20rod%20and%20cone%20responses&journal=Prog%20Retin%20Eye%20Res&doi=10.1016%2Fj.preteyeres.2007.09.003&volume=27&pages=1-44&publication_year=2008&author=Weymouth%2CAE&author=Vingrys%2CAJ?
• How much does https://doi.org/10.1016%2F0014-4835%2891%2990215-Z gross monthly?
• http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1991elpa.book.....H's revenue stream
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1743256 generate monthly?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Quantitation%20of%20ischemic%20damage%20in%20the%20rat%20retina&journal=Exp%20Eye%20Res&doi=10.1016%2F0014-4835%2891%2990215-Z&volume=53&pages=573-582&publication_year=1991&author=Hughes%2CWF?
• What's the profit of https://doi.org/10.1167%2Fiovs.09-4086?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Retinal%20protection%20from%20acute%20glaucoma-induced%20ischemia-reperfusion%20injury%20through%20pharmacologic%20induction%20of%20heme%20oxygenase-1&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.09-4086&volume=51&pages=4798-4808&publication_year=2010&author=Sun%2CMH?
• What's the revenue for https://doi.org/10.1016%2FS0306-3623%2897%2900359-5?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9510075 produce monthly?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=The%20b-wave%20of%20the%20electroretinogram%20as%20an%20index%20of%20retinal%20ischemia&journal=Gen%20Pharmacol&doi=10.1016%2FS0306-3623%2897%2900359-5&volume=30&pages=281-287&publication_year=1998&author=Block%2CF&author=Schwarz%2CM?
• Earnings of https://doi.org/10.1056%2FNEJMe1103334
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21526924 net monthly?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Bevacizumab%20versus%20ranibizumab%20for%20AMD&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMe1103334&volume=364&pages=1966-1967&publication_year=2011&author=Rosenfeld%2CPJ?
• Learn about the earnings of https://doi.org/10.1056%2FNEJMoa1414264
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25692915
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Aflibercept%2C%20bevacizumab%2C%20or%20ranibizumab%20for%20diabetic%20macular%20edema&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1414264&volume=372&pages=1193-1203&publication_year=2015&author=Wells%2CJA have monthly?
• Monthly income for https://doi.org/10.1016%2FS0161-6420%2891%2932135-3
• How much income is http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20tolerance%20of%20intravitreal%20ganciclovir%20in%20cytomegalovirus%20retinitis%20in%20acquired%20immune%20deficiency%20syndrome&journal=Ophthalmology&doi=10.1016%2FS0161-6420%2891%2932135-3&volume=98&pages=1353-1345&publication_year=1991&author=Cochereau-Massin%2CI earning monthly?
• https://doi.org/10.1111%2Fj.1755-3768.2011.02247.x's financial summary
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21914149 making per month?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Repeat%20intravitreal%20triamcinolone%20acetonide%20injections%20in%20uveitic%20macular%20oedema&journal=Acta%20Ophthalmol&doi=10.1111%2Fj.1755-3768.2011.02247.x&volume=90&pages=e323-325&publication_year=2012&author=Sallam%2CA
• How profitable is https://citation-needed.springer.com/v2/references/10.1038/srep44873?format=refman&flavour=references?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masayuki%20Hata
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masayuki%20Hata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hanako%20O.%20Ikeda bring in each month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hanako%20O.%20Ikeda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chinami%20Kikkawa's revenue stream
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chinami%20Kikkawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sachiko%20Iwai?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sachiko%20Iwai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Muraoka?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Muraoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tomoko%20Hasegawa net monthly?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tomoko%20Hasegawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Kakizuka make?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Kakizuka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nagahisa%20Yoshimura each month?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nagahisa%20Yoshimura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Profit of https://static-content.springer.com/esm/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_BFsrep44873_MOESM49_ESM.pdf
• What's the monthly money flow for http://creativecommons.org/licenses/by/4.0/?
• How much does https://s100.copyright.com/AppDispatchServlet?title=KUS121%2C%20a%20VCP%20modulator%2C%20attenuates%20ischemic%20retinal%20cell%20death%20via%20suppressing%20endoplasmic%20reticulum%20stress&author=Masayuki%20Hata%20et%20al&contentID=10.1038%2Fsrep44873©right=The%20Author%28s%29&publication=2045-2322&publicationDate=2017-03-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY bring in each month?
• How much does https://crossmark.crossref.org/dialog/?doi=10.1038/srep44873 pull in monthly?
• Earnings of https://citation-needed.springer.com/v2/references/10.1038/srep44873?format=refman&flavour=citation
• Earnings of https://doi.org/10.1038/s41420-022-01007-3
• What's the monthly money flow for https://doi.org/10.1038/s41598-022-20497-w?
• What's the financial outcome of https://doi.org/10.1038/s41598-021-95173-6?
• How much does https://doi.org/10.1038/s41598-020-61160-6 net monthly?
• Income figures for https://doi.org/10.1038/s41598-020-77735-2
• Get to know what's the income of https://www.protocols.io/
• Find out how much https://www.natureindex.com/ earns monthly
• Income figures for http://www.naturechina.com
• What are the total earnings of https://www.natureasia.com/ja-jp?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref